Cargando…
OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIV® + AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767552/ http://dx.doi.org/10.1186/1742-4690-6-S3-O30 |
_version_ | 1782173320667463680 |
---|---|
author | Kim, JH Kamasuta, C Trichavaroj, R Kaewkungwal, J Chantakulkij, S Ratto-Kim, S Eamsila, C Sukwit, S Nitayaphan, S Pitsuttihum, P Michael, NL Chiu, J Rerks-Ngarm, S de Souza, MS Paris, RM |
author_facet | Kim, JH Kamasuta, C Trichavaroj, R Kaewkungwal, J Chantakulkij, S Ratto-Kim, S Eamsila, C Sukwit, S Nitayaphan, S Pitsuttihum, P Michael, NL Chiu, J Rerks-Ngarm, S de Souza, MS Paris, RM |
author_sort | Kim, JH |
collection | PubMed |
description | |
format | Text |
id | pubmed-2767552 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-27675522009-10-28 OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIV® + AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial Kim, JH Kamasuta, C Trichavaroj, R Kaewkungwal, J Chantakulkij, S Ratto-Kim, S Eamsila, C Sukwit, S Nitayaphan, S Pitsuttihum, P Michael, NL Chiu, J Rerks-Ngarm, S de Souza, MS Paris, RM Retrovirology Oral Presentation BioMed Central 2009-10-22 /pmc/articles/PMC2767552/ http://dx.doi.org/10.1186/1742-4690-6-S3-O30 Text en Copyright © 2009 BioMed Central Ltd. |
spellingShingle | Oral Presentation Kim, JH Kamasuta, C Trichavaroj, R Kaewkungwal, J Chantakulkij, S Ratto-Kim, S Eamsila, C Sukwit, S Nitayaphan, S Pitsuttihum, P Michael, NL Chiu, J Rerks-Ngarm, S de Souza, MS Paris, RM OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIV® + AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial |
title | OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIV® + AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial |
title_full | OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIV® + AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial |
title_fullStr | OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIV® + AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial |
title_full_unstemmed | OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIV® + AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial |
title_short | OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIV® + AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial |
title_sort | oa04-06 lb. post-infection cellular immune responses in recipients following alvac-hiv® + aidsvax® b/e prime-boost vaccination in the thai phase iii trial |
topic | Oral Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767552/ http://dx.doi.org/10.1186/1742-4690-6-S3-O30 |
work_keys_str_mv | AT kimjh oa0406lbpostinfectioncellularimmuneresponsesinrecipientsfollowingalvachivaidsvaxbeprimeboostvaccinationinthethaiphaseiiitrial AT kamasutac oa0406lbpostinfectioncellularimmuneresponsesinrecipientsfollowingalvachivaidsvaxbeprimeboostvaccinationinthethaiphaseiiitrial AT trichavarojr oa0406lbpostinfectioncellularimmuneresponsesinrecipientsfollowingalvachivaidsvaxbeprimeboostvaccinationinthethaiphaseiiitrial AT kaewkungwalj oa0406lbpostinfectioncellularimmuneresponsesinrecipientsfollowingalvachivaidsvaxbeprimeboostvaccinationinthethaiphaseiiitrial AT chantakulkijs oa0406lbpostinfectioncellularimmuneresponsesinrecipientsfollowingalvachivaidsvaxbeprimeboostvaccinationinthethaiphaseiiitrial AT rattokims oa0406lbpostinfectioncellularimmuneresponsesinrecipientsfollowingalvachivaidsvaxbeprimeboostvaccinationinthethaiphaseiiitrial AT eamsilac oa0406lbpostinfectioncellularimmuneresponsesinrecipientsfollowingalvachivaidsvaxbeprimeboostvaccinationinthethaiphaseiiitrial AT sukwits oa0406lbpostinfectioncellularimmuneresponsesinrecipientsfollowingalvachivaidsvaxbeprimeboostvaccinationinthethaiphaseiiitrial AT nitayaphans oa0406lbpostinfectioncellularimmuneresponsesinrecipientsfollowingalvachivaidsvaxbeprimeboostvaccinationinthethaiphaseiiitrial AT pitsuttihump oa0406lbpostinfectioncellularimmuneresponsesinrecipientsfollowingalvachivaidsvaxbeprimeboostvaccinationinthethaiphaseiiitrial AT michaelnl oa0406lbpostinfectioncellularimmuneresponsesinrecipientsfollowingalvachivaidsvaxbeprimeboostvaccinationinthethaiphaseiiitrial AT chiuj oa0406lbpostinfectioncellularimmuneresponsesinrecipientsfollowingalvachivaidsvaxbeprimeboostvaccinationinthethaiphaseiiitrial AT rerksngarms oa0406lbpostinfectioncellularimmuneresponsesinrecipientsfollowingalvachivaidsvaxbeprimeboostvaccinationinthethaiphaseiiitrial AT desouzams oa0406lbpostinfectioncellularimmuneresponsesinrecipientsfollowingalvachivaidsvaxbeprimeboostvaccinationinthethaiphaseiiitrial AT parisrm oa0406lbpostinfectioncellularimmuneresponsesinrecipientsfollowingalvachivaidsvaxbeprimeboostvaccinationinthethaiphaseiiitrial |